Biocidal Agents Synergistic Mixture Reduces Foaming

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current biocidal agents containing 1,2-benzisothiazolin-3-one (BIT) and N-alkylguanidinium salts face issues such as foaming, high dosage requirements, and insufficient effectiveness against certain microorganisms, particularly in outdoor applications where water solubility leads to leaching, and there is a need for improved synergistic mixtures against bacteria, fungi, and algae.

Innovation Solution

Formulations combining BIT, 2-methyl-4-isothiazolin-3-one (MIT), and N-alkylguanidinium salts, specifically n-dodecylguanidinium salts, in varying ratios, along with optional additional biocides, to create strong, broad-spectrum biocidal agents for protecting technical materials from microbial infestation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If larger amounts of N-alkylguanidinium salts are used to achieve satisfactory antimicrobial results, then effectiveness against microorganisms is improved, but foaming occurs which makes use difficult or impossible

Engineering Contradiction:
Improveantimicrobial effectivenessVSAvoidfoaming
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent combines N-alkylguanidinium salts with BIT and/or MIT to create a synergistic mixture. This merging of biocidal agents allows lower dosages of the guanidinium salt to be used while maintaining or enhancing antimicrobial effectiveness, thereby reducing foaming issues while achieving reliable microbial control.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention creates a composite biocidal system by formulating N-alkylguanidinium salts together with BIT and/or MIT. This composite approach leverages the complementary properties of each component: the broad-spectrum activity of BIT/MIT and the rapid action of guanidinium salts, achieving effective microbial protection at lower, non-foaming concentrations.

Inventive Principle:
Principle #40Composite materials

2Reliability

If very high dosage quantities of N-alkylguanidinium salts are used to achieve satisfactory antimicrobial results, then effectiveness against microorganisms is improved, but the cost and complexity of application increase

Engineering Contradiction:
Improveantimicrobial effectivenessVSAvoiddosage quantity
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

By merging N-alkylguanidinium salts with BIT and/or MIT in a formulated mixture, the patent achieves synergistic antimicrobial activity. This allows the use of lower dosage quantities compared to using high amounts of guanidinium salt alone, while maintaining or improving effectiveness against a broader range of microorganisms.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention changes the concentration parameters by formulating a mixture where BIT and/or MIT enable reduced dosages of N-alkylguanidinium salt. The synergistic interaction allows effective microbial control at optimized, lower concentrations, reducing the quantity of substance required while maintaining reliability.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If high water solubility of N-alkylguanidinium salts is utilized for easy application, then ease of operation is improved, but leaching occurs quickly in outdoor applications

Engineering Contradiction:
Improvewater solubilityVSAvoidresistance to leaching
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent merges N-alkylguanidinium salts with BIT and/or MIT to create a balanced formulation. This combination allows the biocidal system to benefit from the water solubility and ease of application of the guanidinium salt while the BIT/MIT component provides enhanced stability and resistance to leaching, achieving both ease of operation and reliability in outdoor applications.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentEP3038468B1Microbicidal agents
Publication Date: 2017.08.16 LANXESS DEUTSCHLAND GMBH
  • EP3038468B1 patent drawing

AI summary

The invention relates to biocidal substances containing at least one isothiazolinone from the group consisting of 1,2-benzisothiazolin-3-one (BIT) and 2-methyl-4-isothiazolin-3-one (MIT) and at least one N-alkyl-guanidinium salt, to methods for the production thereof and to the use thereof for protecting against technical materials and products which can be infected by micro-organisms.